| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADAPY (ADAPY) has 4 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. ADAPY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 100.37M | $3.41M | - | |
| COO | 986.4K | $33.5K | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2016 | Sigal Charles Elliott | Director | Buy | 15,000 | $1.56 | $23,400.00 | +5.0% | |
| May 18, 2016 | Sigal Charles Elliott | Director | Buy | 45,000 | $1.53 | $68,700.00 | +5.6% |